A detailed history of First Financial Bank Trust Division transactions in Eli Lilly & CO stock. As of the latest transaction made, First Financial Bank Trust Division holds 1,826 shares of LLY stock, worth $1.57 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,826
Previous 1,728 5.67%
Holding current value
$1.57 Million
Previous $1.34 Million 22.99%
% of portfolio
0.16%
Previous 0.13%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

BUY
$724.87 - $909.04 $71,037 - $89,085
98 Added 5.67%
1,826 $1.65 Million
Q1 2024

Apr 01, 2024

SELL
$592.2 - $792.28 $11,844 - $15,845
-20 Reduced 1.14%
1,728 $1.34 Million
Q4 2023

Jan 02, 2024

SELL
$525.19 - $619.13 $5,251 - $6,191
-10 Reduced 0.57%
1,748 $1.02 Million
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $1.96 Million - $2.7 Million
-4,505 Reduced 71.93%
1,758 $944,000
Q2 2023

Jul 03, 2023

SELL
$350.74 - $468.98 $17,186 - $22,980
-49 Reduced 0.78%
6,263 $2.94 Million
Q1 2023

Apr 03, 2023

SELL
$310.63 - $364.82 $89,461 - $105,068
-288 Reduced 4.36%
6,312 $2.17 Million
Q4 2022

Jan 03, 2023

SELL
$321.55 - $374.67 $62,380 - $72,685
-194 Reduced 2.86%
6,600 $2.41 Million
Q3 2022

Oct 04, 2022

SELL
$296.48 - $337.87 $316,344 - $360,507
-1,067 Reduced 13.57%
6,794 $2.2 Million
Q2 2022

Jul 01, 2022

SELL
$278.73 - $327.27 $30,381 - $35,672
-109 Reduced 1.37%
7,861 $2.55 Million
Q1 2022

Apr 04, 2022

SELL
$234.69 - $291.66 $29,570 - $36,749
-126 Reduced 1.56%
7,970 $2.28 Million
Q2 2021

Jul 07, 2021

SELL
$180.55 - $233.54 $73,844 - $95,517
-409 Reduced 4.81%
8,096 $1.86 Million
Q1 2021

Apr 05, 2021

BUY
$164.32 - $212.72 $16,432 - $21,272
100 Added 1.19%
8,505 $1.59 Million
Q4 2020

Jan 05, 2021

SELL
$130.46 - $172.63 $39,138 - $51,789
-300 Reduced 3.45%
8,405 $1.42 Million
Q3 2020

Oct 02, 2020

SELL
$146.22 - $169.13 $31,437 - $36,362
-215 Reduced 2.41%
8,705 $1.29 Million
Q2 2020

Jul 02, 2020

BUY
$136.42 - $164.18 $806,105 - $970,139
5,909 Added 196.25%
8,920 $1.47 Million
Q1 2020

Apr 01, 2020

SELL
$119.05 - $147.35 $32,619 - $40,373
-274 Reduced 8.34%
3,011 $417,000
Q4 2019

Jan 03, 2020

BUY
$106.92 - $132.43 $5,025 - $6,224
47 Added 1.45%
3,285 $431,000
Q3 2019

Oct 04, 2019

SELL
$106.79 - $116.16 $23,920 - $26,019
-224 Reduced 6.47%
3,238 $362,000
Q4 2018

Jan 03, 2019

SELL
$105.9 - $118.64 $128,456 - $143,910
-1,213 Reduced 25.95%
3,462 $400,000
Q3 2018

Oct 03, 2018

SELL
$85.86 - $107.31 $24,040 - $30,046
-280 Reduced 5.65%
4,675 $502,000
Q2 2018

Jul 05, 2018

BUY
$75.7 - $86.88 $11,355 - $13,032
150 Added 3.12%
4,955 $423,000
Q1 2018

Apr 04, 2018

BUY
$74.21 - $87.6 $356,579 - $420,918
4,805 New
4,805 $372,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $815B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Financial Bank Trust Division Portfolio

Follow First Financial Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on First Financial Bank Trust Division with notifications on news.